newsfilter
← Latest News
PR Newswire·

Eiger BioPharmaceuticals to Present at H.C. Wainwright BioConnect 2022 Virtual Conference

PALO ALTO, Calif., Jan. 3, 2022 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR), a commercial-stage biopharmaceutical company focused on the development of innovative therapies to treat and cure Hepatitis Delta Virus (HDV) and other serious